In the Press

Filters
Type
Sectors
Geography
Companies

Sign up for our free
equity research notes

Register
1617 Results
Embed
James Carthew comments on growth capital trusts in Investors’ Chronicle

James Carthew comments on the growth capital sector and trusts in Val Cipriani’s article: “The problem [with Schiehallion] is that investors got over excited in 2021 and the unwinding of a significant premium upset a lot of shareholders. I think we are past the worst here,” Read the article here

James Carthew comments on new Saba proposals in Investment Week

James Carthew comments on Saba’s open letter and proposals in Michael Nelson’s article: “We still see no evidence that investors in EWI, Herald, Impax Environmental and the many other trusts that Saba has targeted want to be invested in an activist strategy. If Saba is adamant that they do, why does it not try to […]

Biotech trusts top performance charts in February
James Carthew comments on Saba open letter and proposals in Portfolio Adviser

James Carthew comments on Saba’s open letter and new proposals in Lauren Hardy’s article: “We still see no evidence that investors in EWI, Herald, Impax Environmental and the many other trusts that Saba has targeted want to be invested in an activist strategy. If Saba is adamant that they do, why doesn’t it try to […]

Investment trust insider on US trusts

James Carthew: How trusts are swapping mega-caps for value Markets are beginning to look beyond the small handful of mega-cap stocks that have long led returns. For many years, US equities have been dominated by a narrow group of mega-cap stocks. The meteoric rise of companies such as Nvidia sucked the air out of the […]

the citywire investment trust insider logo
James Carthew comments on recent FCA blog in Portfolio Adviser

James Carthew comments on the FCA’s recent blog on trusts in Patrick Sanders’ article: “It feels to me as though if Saba disputed whether its actions were vexatious, there is a good chance that a judge would side with them. “That implies that the trust might incur substantial legal fees for no ultimate benefit, and […]

Matthew Read comments on HRI’s update in Sharesify

Matthew Read comments on HRI’s latest update in James Crux’s article: “Given the strong backing for the existing manager from non-Saba Herald shareholders – and the potential CGT implications for long-term holders in particular – it is encouraging that the board continues to explore a negotiated solution with Saba.” Read the article here

Matthew Read comments on the latest update from HRI in Investment Week

Matthew Read comments on the update from HRI in Linus Uhlig’s article: “It is sensible that the manager has begun reducing some of Herald’s less liquid positions to limit the impact of any forced disposals, whether through a backstop tender or a larger-than-expected cash exit,” Read the article here

Biotech trusts top performance charts in February
Matthew Read comments on ALW fee cut in Citywire

Matthew Read comments on ALW’s fee cut in Lotte Edwards’ article saying it “reinforces what was already a highly competitive cost structure” Read the article here

Investment Trust Insider on Capital Gearing Trust
Richard Williams comments on the offer for Picton in Portfolio Adviser

Richard Williams comments on the consortium offer for PCTN in Patrick Sanders’ article: “There are some strong performing retail warehouses and offices in the portfolio, and if acquired at the right price, could provide SREI with some solid income and growth potential.” Read the article here

Richard Williams comments on reit M&A in Investment Week

Richard Williams comments on the reit M&A activity in Michael Nelson’s article: “Both trusts focus on smaller lot size properties that fall below the radar of institutional investors, so it makes sense that the two former stablemate AEW REITs merge,” Read the article here

Biotech trusts top performance charts in February